219 related articles for article (PubMed ID: 28509392)
21. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis.
Kew MC
Liver Int; 2003 Dec; 23(6):405-9. PubMed ID: 14986813
[TBL] [Abstract][Full Text] [Related]
22. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
23. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
[TBL] [Abstract][Full Text] [Related]
24. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
[TBL] [Abstract][Full Text] [Related]
26. Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan.
Wu HC; Wang Q; Wang LW; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
Cancer Lett; 2007 Jul; 252(1):104-14. PubMed ID: 17250958
[TBL] [Abstract][Full Text] [Related]
27. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
Hoque A; Patt YZ; Yoffe B; Groopman JD; Greenblatt MS; Zhang YJ; Santella RM
Nutr Cancer; 1999; 35(1):27-33. PubMed ID: 10624703
[TBL] [Abstract][Full Text] [Related]
28. Aflatoxin levels in chronic hepatitis B patients with cirrhosis or hepatocellular carcinoma in Balıkesir, Turkey.
Aydın M; Aydın S; Bacanlı M; Başaran N
J Viral Hepat; 2015 Nov; 22(11):926-35. PubMed ID: 25894298
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of aflatoxin B1 in liver biopsies of proven hepatocellular carcinoma in India determined by an in-house immunoperoxidase test.
Murugavel KG; Naranatt PP; Shankar EM; Mathews S; Raghuram K; Rajasambandam P; Jayanthi V; Surendran R; Murali A; Srinivas U; Palaniswamy KR; Srikumari D; Thyagarajan SP
J Med Microbiol; 2007 Nov; 56(Pt 11):1455-1459. PubMed ID: 17965344
[TBL] [Abstract][Full Text] [Related]
30. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives.
Yu MW; Chang HC; Liaw YF; Lin SM; Lee SD; Liu CJ; Chen PJ; Hsiao TJ; Lee PH; Chen CJ
J Natl Cancer Inst; 2000 Jul; 92(14):1159-64. PubMed ID: 10904089
[TBL] [Abstract][Full Text] [Related]
31. Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China.
Xu L; Qian G; Tang L; Su J; Wang JS
J Hepatol; 2010 Oct; 53(4):671-6. PubMed ID: 20650537
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma.
Cohen D; Ghosh S; Shimakawa Y; Ramou N; Garcia PS; Dubois A; Guillot C; Kakwata-Nkor Deluce N; Tilloy V; Durand G; Voegele C; Ndow G; d'Alessandro U; Brochier-Armanet C; Alain S; Le Calvez-Kelm F; Hall J; Zoulim F; Mendy M; Thursz M; Lemoine M; Chemin I
JHEP Rep; 2020 Oct; 2(5):100144. PubMed ID: 32904132
[TBL] [Abstract][Full Text] [Related]
33. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.
Mendy ME; Welzel T; Lesi OA; Hainaut P; Hall AJ; Kuniholm MH; McConkey S; Goedert JJ; Kaye S; Rowland-Jones S; Whittle H; Kirk GD
J Viral Hepat; 2010 Feb; 17(2):115-22. PubMed ID: 19874478
[TBL] [Abstract][Full Text] [Related]
35. Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype.
Ahsan H; Wang LY; Chen CJ; Tsai WY; Santella RM
Environ Health Perspect; 2001 Aug; 109(8):833-7. PubMed ID: 11564620
[TBL] [Abstract][Full Text] [Related]
36. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
37. Association between aflatoxin B1 occupational airway exposure and risk of hepatocellular carcinoma: a case-control study.
Lai H; Mo X; Yang Y; He K; Xiao J; Liu C; Chen J; Lin Y
Tumour Biol; 2014 Oct; 35(10):9577-84. PubMed ID: 24961349
[TBL] [Abstract][Full Text] [Related]
38. Clinical features of aflatoxin B1-exposed patients with liver cancer and the molecular mechanism of aflatoxin B1 on liver cancer cells.
Zhou R; Liu M; Liang X; Su M; Li R
Environ Toxicol Pharmacol; 2019 Oct; 71():103225. PubMed ID: 31376682
[TBL] [Abstract][Full Text] [Related]
39. [The association between aflatoxin exposure and primary hepatocellular carcinoma risks: a case-control study in Chongqing].
Zheng CF; Zeng H; Wang J; Lin H; Feng XB; Chen JA; Qiu ZQ; Luo JH; Xu AW; Wang LQ; Tan Y; Chen S; Jiang P; Shu WQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):539-545. PubMed ID: 28592100
[No Abstract] [Full Text] [Related]
40. Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.
Liu ZM; Li LQ; Peng MH; Liu TW; Qin Z; Guo Y; Xiao KY; Ye XP; Mo XS; Qin X; Li S; Yan LN; Shen HM; Wang L; Wang Q; Wang KB; Liang RX; Wei ZL; Ong CN; Santella RM; Peng T
Cancer Lett; 2008 May; 263(2):212-22. PubMed ID: 18280645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
